Cite

    Andrew Burgess et al.. “Eligibility for anti‐fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing.” Respirology, vol. 24, no. 10, 2019, pp. 988–995. http://access.bl.uk/ark:/81055/vdc_100091311097.0x000028